Akso Health Group ADR (AHG)vsHenry Schein Inc (HSIC)
AHG
Akso Health Group ADR
$2.36
-2.48%
HEALTHCARE · Cap: $807.33M
HSIC
Henry Schein Inc
$72.29
-0.54%
HEALTHCARE · Cap: $8.51B
Smart Verdict
WallStSmart Research — data-driven comparison
Henry Schein Inc generates 89115% more annual revenue ($13.18B vs $14.78M). HSIC leads profitability with a 3.0% profit margin vs 0.0%. HSIC earns a higher WallStSmart Score of 56/100 (C).
AHG
Avoid24
out of 100
Grade: F
HSIC
Buy56
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for AHG.
Margin of Safety
+12.5%
Fair Value
$93.39
Current Price
$72.29
$21.10 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 415.8% year-over-year
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Reasonable price relative to book value
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Expensive relative to growth rate
3.0% margin — thin
Elevated debt levels
Comparative Analysis Report
WallStSmart ResearchBull Case : AHG
The strongest argument for AHG centers on Revenue Growth, Debt/Equity, Altman Z-Score. Revenue growth of 415.8% demonstrates continued momentum.
Bull Case : HSIC
The strongest argument for HSIC centers on Price/Book.
Bear Case : AHG
The primary concerns for AHG are EPS Growth, Market Cap, Profit Margin.
Bear Case : HSIC
The primary concerns for HSIC are PEG Ratio, Profit Margin, Debt/Equity. Thin 3.0% margins leave little buffer for downturns.
Key Dynamics to Monitor
AHG profiles as a hypergrowth stock while HSIC is a value play — different risk/reward profiles.
HSIC carries more volatility with a beta of 0.85 — expect wider price swings.
AHG is growing revenue faster at 415.8% — sustainability is the question.
HSIC generates stronger free cash flow (338M), providing more financial flexibility.
Bottom Line
HSIC scores higher overall (56/100 vs 24/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Akso Health Group ADR
HEALTHCARE · MEDICAL DISTRIBUTION · China
Akso Health Group ADR is a leading entity in the healthcare sector, focused on delivering innovative medical solutions and integrated patient care services. With a specialization in advanced health technologies, the company is well-positioned to tap into growth opportunities in telehealth and personalized medicine, bolstered by a strong commitment to research and development. Its robust business model and dedication to quality, supported by a skilled team of professionals, make Akso Health Group an appealing investment for institutional investors aiming to navigate the transformative landscape of healthcare.
Visit Website →Henry Schein Inc
HEALTHCARE · MEDICAL DISTRIBUTION · USA
Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
Visit Website →Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?